1/190
Looks like no tags are added yet.
Conventional drug delivery pros
Easily manufactured
Conventional drug delivery cons
Nonspecific delivery high dosage required rapid elimination adverse effects
Goal of targeted drug delivery
Optimize therapeutic index by localizing drug activity at diseased site
Reduce toxicity increase efficacy widen therapeutic index
Organ targeting
Delivering drugs to specific organs
Systemic targeting
Delivering drugs to biological systems
Cellular targeting
Delivering drugs to specific cell types
Molecular targeting
Targeting intracellular organelles or molecules
Magic Bullet concept
Paul Ehrlich's idea of selective drug targeting
Passive targeting definition
Utilizes natural biodistribution and physiological features for drug accumulation
Active targeting definition
Uses ligands or antibodies to bind specific receptors on target cells
High specificity
Reduced toxicity fewer systemic effects
Disadvantage: Harder to synthesize requires ligand attachment
Passive targeting specificity
Low specificity
Passive targeting engineering difficulty
Easier to synthesize
Passive targeting side effects
More side effects and toxicity
First-order TDDS
Delivers drugs to capillary beds of target organs
Second-order TDDS
Delivers drugs to specific cell types
Third-order TDDS
Delivers drugs to intracellular organelles
Example first-order TDDS
Eye lymphatics pleural cavity joints cerebral space
Example second-order TDDS
Hepatocyte targeting via asialoglycoprotein receptors
Example third-order TDDS
Antibody-drug conjugates targeting endosome or cytoplasm
TDDS considerations
Each tissue has unique physiology affecting drug delivery
Identify antigens or proteins unique to target site
Drug stability physicochemical properties formulation needs
Selection of particulate systems or targeted conjugates (modality)
Ideal TDDS properties
Targets drug to intended cell or tissue
Prevents premature drug escape
Protects drug from metabolic degradation
Keeps drug at target long enough for action
Facilitates entry into cell
Delivers drug to correct organelle
Biodegradable biocompatible non-antigenic
TDDS components
Provides therapeutic action (API)
Improves drug distribution protects from metabolism reduces clearance (carrier system)
Ligand that targets specific cells or tissues (homing device - only active targeting)
Homing device requirement
Not required for passive targeting
Soluble macromolecular carriers
Prodrugs monoclonal antibodies immunotoxins bispecific antibodies
Particulate carrier systems
Liposomes polymeric nanoparticles microparticles lipoproteins protein nanoparticles
Passive targeting TDDS contents
Active drug plus carrier system
Immunotoxin classification
Soluble macromolecular carrier
Active targeting example
Monoclonal antibody binding tumor antigen
Passive targeting example
Nanoparticle accumulation via EPR effect
Microparticle
Particles 1-1000 µm for sustained release
Benefit: Long-acting injectable drug delivery
Nanoparticle size range
1 to 1000 nanometers
Liposome definition
Spherical vesicle composed of one or more phospholipid bilayers
Liposome hydrophobic drug location
Lipid bilayer
Liposome hydrophilic drug location
Aqueous core
SUV definition
Small unilamellar vesicle
LUV definition
Large unilamellar vesicle
GUV definition
Giant unilamellar vesicle
Liposome phospholipid examples
Phosphatidylcholine phosphatidylethanolamine phosphatidylserine sphingomyelin
Liposome sterol function
Regulates membrane fluidity and stability
Most common sterol
Cholesterol
PEG in liposomes function
Increases circulation time prevents clearance enhances stability
Charged lipid function
Encapsulates anionic drugs aids intracellular delivery
Liposome advantage solubility
Can deliver hydrophilic and hydrophobic drugs
Liposome advantage targeting
Allows sustained and targeted delivery
Liposome advantage safety
Biocompatible non-toxic non-immunogenic
Liposome disadvantages
Low solubility in aqueous media
Short circulation half-life
High cost to manufacture
Leakage fusion oxidation allergic reactions
Conventional liposome definition
First-generation liposome using natural phospholipids and cholesterol
DaunoXome composition
DSPC cholesterol daunorubicin
AmBisome composition
HSPC DSPG cholesterol amphotericin B
Stealth liposome definition
PEGylated liposome with extended circulation
Doxil composition
HSPC MPEG-2000-DSPE cholesterol doxorubicin
Onivyde composition
DSPC MPEG-2000-DSPE cholesterol irinotecan is the compsition of what drug
Immunoliposome definition
Liposome with antibodies for active targeting
Immunoliposome use
Targeted delivery of anticancer drugs
Lipid nanoparticle definition
Lipid-based nanoparticle especially for nucleic acid delivery
LNP advantage clinical maturity
Most advanced non-viral gene delivery system
Liposome vs LNP aqueous core
Liposomes have aqueous core LNPs do not
Liposome vs LNP bilayer
Liposomes have bilayer LNPs have monolayer
Nucleic acid therapeutic classes
mRNA and synthetic oligonucleotides
Oligonucleotide types
ASO siRNA saRNA aptamers gRNA
Nucleic acid challenge enzymatic
Degraded by nucleases
Nucleic acid challenge delivery barrier
Large hydrophilic anionic cannot cross membranes
Nucleic acid challenge off-targeting
Need targeting to reduce toxicity
Nucleic acid challenge intracellular
Must reach cytoplasm or nucleus
NA chemical instability
Hydrolysis oxidation deamination depyrimidination
NA physical instability
Temperature pH oxygen UV metal ions damage
Freeze-drying benefit
Improves stability prevents degradation
LNP advantage cell delivery
Optimized uptake and cytoplasmic release
LNP advantage NA protection
Protects nucleic acids from degradation
LNP disadvantages
Expensive manufacturing
Variable cytoplasmic release
LNP components
Ionizable cationic lipid (ionizable lipid)
DSPC (Phospholipid)
Cholesterol (stabilizer)
DMG-PEG 2000 (PEG lipid)
Phospholipid (helper lipid)
LNP structure
What structure is described here?
Lipid monolayer with multilayer lipid core
RNA therapeutic charge
Hydrophilic and anionic
Cationic lipids definition
Permanently positively charged lipids
Common cationic lipids
DOTMA DOTAP
Ionizable lipids charge behavior
Become protonated at low pH neutral at physiological pH
Ionizable lipid pKa
Between 6 and 7
Ionizable lipids endosomal activity
Endosomal protonation aids escape
Ionizable LNP manufacturing pH
pH 4-4.5
N/P ratio definition
Ratio of amines on lipid to phosphate groups on NA
Typical N/P ratio
About 6
ONPATTRO use
siRNA for transthyretin-mediated amyloidosis
LNP
Fixed cationic lipid example
DOTMA
Ionizable lipids protonated in
Endosomes
Ionizable complexation basis
N/P ratio
Polymeric nanoparticle definition
Colloidal particles 1-1000 nm from polymers
Nanosphere definition
Solid polymer matrix with drug distributed throughout
Nanocapsule definition
Polymeric shell surrounding liquid drug core
Polymersome definition
Vesicle of amphiphilic block copolymers
Polymersome benefit stability
More stable than liposomes
Polymersome size
50 nm to 5 micrometers
Polymeric micelle definition
Amphiphilic copolymers self-assembled with hydrophobic core
Polymeric micelle size
10 to 200 nm
CMC definition
Concentration below which micelles dissociate
Clinically used paclitaxel micelle
Nanoxel M
Clinically used docetaxel micelle
PEG-b-PLA docetaxel micelles
Dendrimer definition
Hyperbranched polymers with surface functional groups
Dendrimer size
5 to 20 nm
Common dendrimer types
PAMAM PEI
Polymeric NP advantages
Tunable chemical physical properties (Tunability)
Controlled drug release
High stability
Biodegradable